Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Encouraging to see the company(APIRx Pharmaceuticals) owner of a similar patent that combines CBD and nicotine in a gum, has been purchased by NASDAQ company Incannex for about 95M..
"Globally, the market for nicotine medicated chewing gums for smoking cessation generates in excess of US$5bn in sales per annum.
The chewing gum delivery method works by releasing nicotine directly into the blood stream through the lining of the mouth to reduce cravings for a cigarette.
While it’s a mature industry, data shows that nicotine gum products still only assist around 15% of the smokers to quit for good.
In that context, the Incannex board believes both of APIRx’s CanQuit treatments have the capacity to materially disrupt the global nicotine gum market. They may achieve this by combining nicotine and CBD to potentially better assist smokers to quit smoking"
Exciting new validation of cv-007 to be presented Thursday during CMCR Symposium. This is a continuation study of the earlier study between cvsi and UCSD.
This was funded by a 750k grant from TRDRP.
https://vimeo.com/699809965?embedded=true&source=vimeo_logo&owner=75905479
The CMCR Symposium
https://www.cmcr.ucsd.edu/index.php/cmcr-2022-symposium
New patent application for TREATMENT OF PSORIASIS
https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=3&f=G&l=50&co1=AND&d=PG01&s1=cannabidiol&s2=palmitoylethanolamide&OS=cannabidiol+AND+palmitoylethanolamide&RS=cannabidiol+AND+palmitoylethanolamide
Happy Lane Forbes Health top cbd capsule pick.
A little fluff but we'll take the advertising.
https://www.forbes.com/health/body/best-cbd-capsules/
High-Dose Cannabidiol for the Treatment of Parkinson’s Related Sleep Dysfunction: Initial Results of a U.S. Case Study
Conclusion
A hemp-based CBD extract demonstrates tolerability and efficacy in improving PD-related sleep abnormalities after 1 month of use. The results noted are clinically significant and the first U.S. documentation of benefits seen in previous case studies utilizing high-dose CBD. Note that only product was provided by CV Sciences, San Diego, California; they were not involved in any aspect of the present research. Patient completed a case study consent as part of a pre-existing institutional review board protocol (IRB-13-6248).
The final payment for the Canadian cv-007 patent has been paid and awaiting issue.
If cv-007 is a viable pharmaceutical then each country's approval should add a lot of value.
https://globaldossier.uspto.gov/svc/doccontent/CA/3021835.A/id00000004216946/1/PDF
Mind numbing. Trying to make sense of the 8 sec filings this past week.
Conclusion is this is a company that can not survive if anything is left to chance
First and foremost the approval to increase authorized shares that failed last years vote has to be approved. to survive. Now it will be a done deal.
Providing more time, We hopefully will have more information before we vote on the BOD before June The preferred vote can not save them if they are leading us astray.
wolf here is link to all sec for cvsi. Should be the first one.
https://ir.cvsciences.com/all-sec-filings?form_type=&year=#
There is a lock up agreement "exhibit D" that I can't find yet.
Also in regards to the warrants there is mention of a reverse split that seems to be tied to a Nasdaq listing. Joe has always said a reverse split would only be used to attain a Nasdaq listing.
“Trigger Date” shall mean the 6th Trading Day immediately following the date of the Reverse Stock Split and the 6th Trading Day immediately following the date the Company completes an up-list on the Nasdaq Capital Market, the Nasdaq Global Market, or the Nasdaq Global Select Market.
Why would Dowling and Grasser bother to cancel all their options? https://ir.cvsciences.com/all-sec-filings/content/0001510964-22-000026/wf-form4_164885852291255.html?TB_iframe=true&height=auto&width=auto&preload=false
Did JD give us a hint in the cc.
The wording would suggest that we are now in discussions with a cv-007 partner.
"we are currently moving slowly AS WE SPEAK to partner the program"
Miles got together with Stuart at EXPO WEST to put together this informative
narrative on the new RELIEF product.
Its unfortunate but what you posted about cvsi wanting to hire a staff accountant could be the hold up with the report. It looks like the staff accountant ad on indeed.com has been upgraded to "urgently hiring".
It would seem with Joe being a CPA they would have this under control.
How about you "SPACE LADY' I believe your a retired accountant?
Anyway, we all know it will get eventually filed.
Not sure what it means but Stuart Tomc said last week that they are working with the former lead toxicologist from Proctor and Gamble. He also said he has visited the Proctor and Gamble Biomedical facility?( can't find anything on this)
Cue: 1hour 56minutes
https://luminarypodcasts.com/listen/robert-scott-bell/the-robert-scott-bell-show/the-rsb-show-3-16-22-sharry-edwards-healing-with-sound-stuart-tomc-rip-cass-ingram-&-bill-sardi/e04d5529-9ba4-495c-b63b-a91b4c4a88b2?country=MX
PR today from rrd.
https://www.businesswire.com/news/home/20220316005248/en/
This huge company R.R. Donnelley & Sons Company says they're helping cvsi to stand out.
https://thoughts.rrd.com/case-study/growing-cbd-company-meets-market-demand-stands-out-on-the-shelf-retail?_ga=2.155063224.1074222242.1647286001-2087006963.1647286001&_gl=1*ow01tk*_ga*MjA4NzAwNjk2My4xNjQ3Mjg2MDAx*_ga_2DQDYY9CC3*MTY0NzI4NjAwMC4xLjAuMTY0NzI4NjAwMC42MA..
How the knowledgeable view cvsi.
HempToday: What’s the pulse in the CBD sector now? What kind of companies do you see surviving the shakeout?
Jennifer Adams: Companies that have established themselves in the pre-existing nutraceutical framework within the U.S. have the best chance of avoiding negative impacts that may come from the FDA in the near future. For example, companies such as CV Sciences, which have set standards within CBD product sectors, are no longer selling some products to non-medically licensed distributors. Though frustrating to some wholesalers in the short term, actions like these show a level of pre-emptive shakeout survival.
https://hemptoday.net/we-consider-the-cbd-boom-to-have-been-both-a-blessing-and-a-curse/
Been seeing more and more of this sponsored type advertising.
https://www.brit.co/cbd-for-pain/
NFL Physicians Society honors BOD Joseph Maroon
https://nflps.org/news/long-time-steelers-neurosurgeon-joseph-c-maroon-md-receives-nflps-top-research-award/
Anyone Living in Northern California? Know a good salesperson? Getting ready for CA AB-45 to kick in.
https://naturalindustryjobs.com/jobs/cv-sciences/broker
Stuart Tomc is the announced speaker March 10th.Back in the public eye spreading the gospel of cvsi.
https://npevirtual.app.swapcard.com/event/natural-products-expo-virtual/planning/UGxhbm5pbmdfNzk4Njgw
excerpts from court filings
Reasons for the Settlement
For Lead Plaintiff, the principal reason for the Settlement is the immediate benefit of a cash recovery to the Class. This benefit must be compared to the uncertainty of being able to prove the allegations in the operative complaint; the uncertainty of having a class of CV Sciences investors certified; the risk that the Court may grant, in whole or in part, some or all of the anticipated motions for summary judgment to be filed by Defendants; the attendant risks of litigation, especially in complex actions such as this, as well as the difficulties and delays inherent in such litigation (including any appeals).
For Defendants, who deny all allegations of wrongdoing or liability whatsoever and deny that any Class Members were damaged, the principal reasons for entering into the Settlement are to bring to an end the substantial burden, expense, uncertainty, and risk of further litigation.
ProCBD will be exhibiting in Florida next week at a large conference for
independent pharmacy owners.
https://www.pdsconference.com/exhibitors-marketplace/
Looks like they have updated the procbd info on the website to get ready.
https://www.pluscbdoil.com/ProCBDinfo.html
Its surprising that cvsi has elected to highlight the low dose THC side of their business. Next month on Thursday March 10 at the Natural Products expo West
they will do a hour presentation
"Optimize Your Health with the Many Benefits of Low Dose THC"
Unless you click on the title you wouldn't know who was doing the presentation.
The only other cannabis companies presenting during the expo are Canopy Growth and CW
https://www.expowest.com/en/events-education/in-person-agenda.html
A new small account with 23 locations. This seems to be their only cbd based product a sign of a cautious company looking for a quality product to introduce to their customers.
https://www.heinens.com/stories/new-at-heinens-hot-products-for-a-cold-winter/
Two news stories today highlight cvsi BOD Joseph Maroon influence in the NFL. One of the grants was rewarded to CMCR here in San Diego.
During the last in person stock holders meeting when the two Joes were walking to the parking lot I jokingly asked DR Maroon if he was able to get the NFL endorsement for our cbd. He smiled and said he was working on it.
https://nflcommunications.com/Pages/NFL-AWARDS-$1-MILLION-TO-STUDY-IMPACT-OF-CANNABIS-AND-CBD-ON-PAIN-MANAGEMENT-.aspx#:~:text=have%20JavaScript%20enabled.-,NFL%20AWARDS%20%241%20MILLION%20TO%20STUDY%20IMPACT,AND%20CBD%20ON%20PAIN%20MANAGEMENT&text=NEW%20YORK%2C%20February%201%2C%202022,Diego%20and%20University%20of%20Regina.
https://www.nref.org/ways-to-give/Honor-Your-Mentor-Funds/Maroon-Noll-Fund
"He is the co-developer of ImPACT, a neurocognitive test that is now the standard of care for concussion Management in the NFL, NHL, MLB, NASCAR and over 12,000 high schools and colleges in the United States. It is the only FDA approved test for concussion evaluation (2016). 23 million athletes have been baseline tested to date".
"He has been the team neurosurgeon for the Pittsburgh Steelers for the past 30 years and the first neurosurgeon appointed in the NFL. He has served as a member of the NFL Head, Neck and Spine Committee since 2007"
Todays presentation has been posted on cvsi website for those that missed it.
https://d1io3yog0oux5.cloudfront.net/_a6042e3ec22b67d36ed2cfbb1546de2f/cvsciences/db/354/2712/pdf/CVSI+IR+Deck+January+2022.pdf
Todays slide presentation has been posted for the virtual conference. You may have to sign in to see it?
https://bit.ly/3zXWIE7
New California bill would allow hemp cbd in dispensarys.
https://leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=202120220AB1656
"This bill would state that MAUCRSA does not prohibit a licensee from manufacturing, distributing, or selling products that contain industrial hemp or cannabinoids, extracts, or derivatives from industrial hemp, if the product complies with all applicable state laws and regulations."
What should be a good indicator of future revenues the CALM gummies have broken the CVSI record for most batches needed to fulfill orders. Since their introduction in May, 19 batches have been produced. There have been 18 batches of the Sleep gummies since May. What seems to show the importance of the GNC account half the batches have been produced in Nov and Dec. In their heyday year of 2019 cvsi produced 18 batches of their #1 seller 15mg (60 count) gel caps
https://www.pluscbdoil.com/certificate-of-analysis-calm-gummies-30-ct.html
After two years of covid cancelled conventions it's good to see Pluscbd
exhibiting in March at the big Natural Products Expo West.
It will be great for the company to have Stuart back doing what he does best. Selling to the masses.
https://www.expowest.com/en/home.html
C web joins cvsi at gnc with their gummies. Seem to be quite a bit more expensive. Scroll down.
https://www.gnc.com/herbs-natural-solutions/cbd-products/
So far it does seem to be a GNC exclusive for cbd ingestibles.
All the competition Wolfman listed are topicals.
As far as I can tell the products were added about 4pm est Thursday to the site, so after the stock market closed. This may be the Northeast Distributer that was mentioned months ago.
A Christmas gift.
The only non topical cbd products at gnc?
On their home page. Scroll down.
https://www.gnc.com/
A new continuation patent application was filed today with uspto. This is in regards to PROCESS FOR GENERATING HEMP OIL WITH A HIGH CANNABIDIOL (CBD) CONTENT. Interesting read on strategies to file a continuation.
https://www.nutter.com/ip-law-bulletin/continuation-patent-applications-10-reasons-you-should-file
A Israeli-UK company (Kanabo) wants to combine cbd and nicotine in a vape cartridge for smoking cessation. Am I the only one who invested in the pharmaceutical side of cvsi? The stock price would suggest so. As long as Melissa Peters is employed at cvsi means cv-007 is still a go.
https://businesscann.com/kanabos-cbd-based-smoking-cessation-formula-moves-closer-to-full-patent-approval/